1. Home
  2. KIM vs MEDP Comparison

KIM vs MEDP Comparison

Compare KIM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIM
  • MEDP
  • Stock Information
  • Founded
  • KIM 1958
  • MEDP 1992
  • Country
  • KIM United States
  • MEDP United States
  • Employees
  • KIM N/A
  • MEDP N/A
  • Industry
  • KIM Real Estate Investment Trusts
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • KIM Real Estate
  • MEDP Health Care
  • Exchange
  • KIM Nasdaq
  • MEDP Nasdaq
  • Market Cap
  • KIM 14.1B
  • MEDP 13.4B
  • IPO Year
  • KIM 1991
  • MEDP 2016
  • Fundamental
  • Price
  • KIM $20.51
  • MEDP $585.82
  • Analyst Decision
  • KIM Buy
  • MEDP Hold
  • Analyst Count
  • KIM 12
  • MEDP 11
  • Target Price
  • KIM $24.92
  • MEDP $451.70
  • AVG Volume (30 Days)
  • KIM 5.4M
  • MEDP 347.3K
  • Earning Date
  • KIM 10-30-2025
  • MEDP 10-22-2025
  • Dividend Yield
  • KIM 5.14%
  • MEDP N/A
  • EPS Growth
  • KIM 57.13
  • MEDP 25.36
  • EPS
  • KIM 0.83
  • MEDP 14.32
  • Revenue
  • KIM $2,123,057,000.00
  • MEDP $2,358,373,000.00
  • Revenue This Year
  • KIM $4.86
  • MEDP $21.48
  • Revenue Next Year
  • KIM $3.18
  • MEDP $11.90
  • P/E Ratio
  • KIM $24.34
  • MEDP $40.87
  • Revenue Growth
  • KIM 8.14
  • MEDP 13.88
  • 52 Week Low
  • KIM $17.93
  • MEDP $250.05
  • 52 Week High
  • KIM $25.83
  • MEDP $625.00
  • Technical
  • Relative Strength Index (RSI)
  • KIM 35.53
  • MEDP 62.02
  • Support Level
  • KIM $20.16
  • MEDP $572.12
  • Resistance Level
  • KIM $20.60
  • MEDP $602.54
  • Average True Range (ATR)
  • KIM 0.44
  • MEDP 20.93
  • MACD
  • KIM -0.16
  • MEDP -0.69
  • Stochastic Oscillator
  • KIM 19.30
  • MEDP 59.40

About KIM Kimco Realty Corporation (HC)

One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: